188 related articles for article (PubMed ID: 29306942)
1. Targeting Neutrophils in Severe Asthma via Siglec-9.
Chen Z; Bai FF; Han L; Zhu J; Zheng T; Zhu Z; Zhou LF
Int Arch Allergy Immunol; 2018; 175(1-2):5-15. PubMed ID: 29306942
[TBL] [Abstract][Full Text] [Related]
2. Sialic acid-binding immunoglobulin-like lectin 9 as a potential therapeutic target for chronic obstructive pulmonary disease.
Chen Z; Xu SL; Ge LY; Zhu J; Zheng T; Zhu Z; Zhou L
Chin Med J (Engl); 2021 Feb; 134(7):757-764. PubMed ID: 33595976
[TBL] [Abstract][Full Text] [Related]
3. Studies on the Detection, Expression, Glycosylation, Dimerization, and Ligand Binding Properties of Mouse Siglec-E.
Siddiqui S; Schwarz F; Springer S; Khedri Z; Yu H; Deng L; Verhagen A; Naito-Matsui Y; Jiang W; Kim D; Zhou J; Ding B; Chen X; Varki N; Varki A
J Biol Chem; 2017 Jan; 292(3):1029-1037. PubMed ID: 27920204
[TBL] [Abstract][Full Text] [Related]
4. Siglec-8 and Siglec-9 binding specificities and endogenous airway ligand distributions and properties.
Yu H; Gonzalez-Gil A; Wei Y; Fernandes SM; Porell RN; Vajn K; Paulson JC; Nycholat CM; Schnaar RL
Glycobiology; 2017 Jul; 27(7):657-668. PubMed ID: 28369504
[TBL] [Abstract][Full Text] [Related]
5. Immunoregulatory Siglec ligands are abundant in human and mouse aorta and are up-regulated by high glucose.
Zhang Y; Zheng Y; Li J; Nie L; Hu Y; Wang F; Liu H; Fernandes SM; Zhong Q; Li X; Schnaar RL; Jia Y
Life Sci; 2019 Jan; 216():189-199. PubMed ID: 30471282
[TBL] [Abstract][Full Text] [Related]
6. Siglec-8 and Siglec-F, the new therapeutic targets in asthma.
Farid SSh; Mirshafiey A; Razavi A
Immunopharmacol Immunotoxicol; 2012 Oct; 34(5):721-6. PubMed ID: 22324980
[TBL] [Abstract][Full Text] [Related]
7. Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions.
Kiwamoto T; Kawasaki N; Paulson JC; Bochner BS
Pharmacol Ther; 2012 Sep; 135(3):327-36. PubMed ID: 22749793
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive Siglec-E ligands on mouse aorta are up-regulated by LPS via NF-κB pathway.
Liu H; Zheng Y; Zhang Y; Li J; Fernandes SM; Zeng D; Li X; Schnaar RL; Jia Y
Biomed Pharmacother; 2020 Feb; 122():109760. PubMed ID: 31918287
[TBL] [Abstract][Full Text] [Related]
9. Viewing Siglecs through the lens of tumor immunology.
Fraschilla I; Pillai S
Immunol Rev; 2017 Mar; 276(1):178-191. PubMed ID: 28258691
[TBL] [Abstract][Full Text] [Related]
10. Regulation of airway inflammation by Siglec-8 and Siglec-9 sialoglycan ligand expression.
Schleimer RP; Schnaar RL; Bochner BS
Curr Opin Allergy Clin Immunol; 2016 Feb; 16(1):24-30. PubMed ID: 26694037
[TBL] [Abstract][Full Text] [Related]
11. Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer.
Läubli H; Pearce OM; Schwarz F; Siddiqui SS; Deng L; Stanczak MA; Deng L; Verhagen A; Secrest P; Lusk C; Schwartz AG; Varki NM; Bui JD; Varki A
Proc Natl Acad Sci U S A; 2014 Sep; 111(39):14211-6. PubMed ID: 25225409
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of Siglec-9 in chronic obstructive pulmonary disease.
Zeng Z; Li M; Wang M; Wu X; Li Q; Ning Q; Zhao J; Xu Y; Xie J
Sci Rep; 2017 Aug; 7(1):10116. PubMed ID: 28860481
[TBL] [Abstract][Full Text] [Related]
13. Expression of ligands for Siglec-8 and Siglec-9 in human airways and airway cells.
Jia Y; Yu H; Fernandes SM; Wei Y; Gonzalez-Gil A; Motari MG; Vajn K; Stevens WW; Peters AT; Bochner BS; Kern RC; Schleimer RP; Schnaar RL
J Allergy Clin Immunol; 2015 Mar; 135(3):799-810.e7. PubMed ID: 25747723
[TBL] [Abstract][Full Text] [Related]
14. Siglec-8 in induced sputum of COPD patients.
Mroz RM; Holownia A; Wielgat P; Sitko A; Skopinski T; Chyczewska E; Braszko JJ
Adv Exp Med Biol; 2013; 788():19-23. PubMed ID: 23835953
[TBL] [Abstract][Full Text] [Related]
15. Host and pathogen hyaluronan signal through human siglec-9 to suppress neutrophil activation.
Secundino I; Lizcano A; Roupé KM; Wang X; Cole JN; Olson J; Ali SR; Dahesh S; Amayreh LK; Henningham A; Varki A; Nizet V
J Mol Med (Berl); 2016 Feb; 94(2):219-33. PubMed ID: 26411873
[TBL] [Abstract][Full Text] [Related]
16. An anti-siglec-8 antibody depletes sputum eosinophils from asthmatic subjects and inhibits lung mast cells.
Kerr SC; Gonzalez JR; Schanin J; Peters MC; Lambrecht BN; Brock EC; Charbit A; Ansel KM; Youngblood BA; Fahy JV
Clin Exp Allergy; 2020 Aug; 50(8):904-914. PubMed ID: 32542913
[TBL] [Abstract][Full Text] [Related]
17. Binding of the sialic acid-binding lectin, Siglec-9, to the membrane mucin, MUC1, induces recruitment of β-catenin and subsequent cell growth.
Tanida S; Akita K; Ishida A; Mori Y; Toda M; Inoue M; Ohta M; Yashiro M; Sawada T; Hirakawa K; Nakada H
J Biol Chem; 2013 Nov; 288(44):31842-52. PubMed ID: 24045940
[TBL] [Abstract][Full Text] [Related]
18. Tamm-Horsfall glycoprotein engages human Siglec-9 to modulate neutrophil activation in the urinary tract.
Patras KA; Coady A; Olson J; Ali SR; RamachandraRao SP; Kumar S; Varki A; Nizet V
Immunol Cell Biol; 2017 Nov; 95(10):960-965. PubMed ID: 28829050
[TBL] [Abstract][Full Text] [Related]
19. Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells.
Lustig M; Chan C; Jansen JHM; Bräutigam M; Kölling MA; Gehlert CL; Baumann N; Mester S; Foss S; Andersen JT; Bastian L; Sondermann P; Peipp M; Burger R; Leusen JHW; Valerius T
Front Immunol; 2023; 14():1178817. PubMed ID: 37346044
[TBL] [Abstract][Full Text] [Related]
20. Expression of Siglec-9 in peripheral blood neutrophils was increased and associated with disease severity in patients with AECOPD.
Ge L; Wang N; Chen Z; Xu S; Zhou L
Cytokine; 2024 May; 177():156558. PubMed ID: 38412768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
